Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Healthtrust
Novartis
Colorcon
Argus Health
Merck
Citi
McKinsey
Fish and Richardson
Moodys

Generated: February 18, 2018

DrugPatentWatch Database Preview

GEMFIBROZIL - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for gemfibrozil and what is the scope of gemfibrozil freedom to operate?

Gemfibrozil
is the generic ingredient in two branded drugs marketed by Mylan, Purepac Pharm, Pfizer Pharms, Apotex, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Caribe Holdings, Chartwell Molecules, Hikma Pharms, Impax Pharms, Invagen Pharms, Northstar Hlthcare, Sun Pharm Inds Inc, Teva, Watson Labs, and Yaopharma Co Ltd, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for gemfibrozil. Fifty-three suppliers are listed for this compound. There is one tentative approval for this compound.
Medical Subject Heading (MeSH) Categories for GEMFIBROZIL
Tentative approvals for GEMFIBROZIL
Applicant Application No. Strength Dosage Form
➤ Try a Free Trial➤ Try a Free Trial300MGCAPSULE;ORAL

US Patents and Regulatory Information for GEMFIBROZIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva GEMFIBROZIL gemfibrozil TABLET;ORAL 074256-001 Oct 31, 1993 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan GEMFIBROZIL gemfibrozil CAPSULE;ORAL 073466-001 Jan 25, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Caribe Holdings GEMFIBROZIL gemfibrozil TABLET;ORAL 078012-001 Mar 26, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Inc GEMFIBROZIL gemfibrozil TABLET;ORAL 079239-001 Dec 29, 2008 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Pharms GEMFIBROZIL gemfibrozil TABLET;ORAL 078207-001 Jun 1, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cadila Pharms Ltd GEMFIBROZIL gemfibrozil TABLET;ORAL 203266-001 Jun 17, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Invagen Pharms GEMFIBROZIL gemfibrozil TABLET;ORAL 077836-001 Jul 27, 2006 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs GEMFIBROZIL gemfibrozil TABLET;ORAL 074156-001 Oct 24, 1994 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Northstar Hlthcare GEMFIBROZIL gemfibrozil TABLET;ORAL 079072-001 Sep 13, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer Pharms LOPID gemfibrozil TABLET;ORAL 018422-003 Nov 20, 1986 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for GEMFIBROZIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms LOPID gemfibrozil CAPSULE;ORAL 018422-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer Pharms LOPID gemfibrozil CAPSULE;ORAL 018422-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
US Department of Justice
Teva
McKesson
McKinsey
Cipla
Argus Health
Healthtrust
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot